循环肿瘤细胞检测在恶性肿瘤治疗及预后评估中的研究进展
Advances in the Research of Circulating Tumor Cell Detection for Malignant Tumor Treatment and Prognostic Assessment
DOI: 10.12677/acm.2024.14112937, PDF,    科研立项经费支持
作者: 韦春莹, 李松霖：右江民族医学院，临床医学院，广西 百色；钟晓刚*：广西壮族自治区人民医院，结直肠肛门外科，广西 南宁
关键词: 循环肿瘤细胞；恶性肿瘤；治疗；个体化医疗；Circulating Tumor Cells； Malignant Tumor； Treatment； Personalized Medicine
摘要: 循环肿瘤细胞(CTCs)作为恶性肿瘤患者血液中的重要生物标志物，其检测技术的不断发展为肿瘤的精准治疗和预后评估提供了新的视角。本综述总结了CTCs的检测技术的特点及近年来CTCs检测在常见恶性肿瘤治疗中的研究进展，探讨其临床应用以及对恶性肿瘤治疗反应评估和患者生存期的预测价值。旨在为进一步完善CTCs的检测技术及为其在科研和临床工作中提供更多的参考价值。
Abstract: Circulating tumor cells (CTCs), as critical biomarkers present in the bloodstream of patients with malignant tumors, have gained significant attention due to the evolving advancements in their detection technologies. This review summarizes the characteristics of CTC detection techniques and highlights recent progress in applying these methods to common malignancies for therapy guidance and prognostic assessment. It explores the clinical utility of CTCs in evaluating treatment response and predicting survival outcomes in cancer patients. The aim is to contribute towards refining CTC detection methodologies and enhancing their applicability in both research and clinical practice, thereby offering enhanced reference value.
文章引用：韦春莹, 钟晓刚, 李松霖. 循环肿瘤细胞检测在恶性肿瘤治疗及预后评估中的研究进展[J]. 临床医学进展, 2024, 14(11): 721-726. https://doi.org/10.12677/acm.2024.14112937

参考文献

[1] Costa, C. and Dávila-Ibáñez, A.B. (2020) Methodology for the Isolation and Analysis of CTCs. In: Piñeiro, R., Eds., Circulating Tumor Cells in Breast Cancer Metastatic Disease, Springer International Publishing, 45-59. [Google Scholar] [CrossRef] [PubMed]
[2] 王红兵. 液体活检在恶性肿瘤中的应用[J]. 实用医院临床杂志, 2022, 19(5): 198-202.
[3] 李一林, 陈杨, 李艳艳, 等. 循环肿瘤细胞检测在常见恶性肿瘤精准医学中的应用和展望[J]. 诊断学理论与实践, 2023, 22(4): 332-340.
[4] 郝少龙, 刘新承, 刘日明, 等. 实体恶性肿瘤循环肿瘤细胞检测的研究进展[J]. 中华普外科手术学杂志(电子版), 2016, 10(5): 638-640.
[5] Castro-Giner, F. and Aceto, N. (2020) Tracking Cancer Progression: From Circulating Tumor Cells to Metastasis. Genome Medicine, 12, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[6] Jelski, W. and Mroczko, B. (2022) Molecular and Circulating Biomarkers of Gastric Cancer. International Journal of Molecular Sciences, 23, Article 7588. [Google Scholar] [CrossRef] [PubMed]
[7] Li, W., Liu, J., Hou, L., Yu, F., Zhang, J., Wu, W., et al. (2022) Liquid Biopsy in Lung Cancer: Significance in Diagnostics, Prediction, and Treatment Monitoring. Molecular Cancer, 21, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[8] Li, C., Shao, J., Li, P., Feng, J., Li, J. and Wang, C. (2023) Circulating Tumor DNA as Liquid Biopsy in Lung Cancer: Biological Characteristics and Clinical Integration. Cancer Letters, 577, Article 216365. [Google Scholar] [CrossRef] [PubMed]
[9] Casagrande, G.M.S., de Oliveira Silva, M., Reis, R.M. and Leal, L.F. (2023) Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. International Journal of Molecular Sciences, 24, Article 2505. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, Y., Ren, X., Jiang, T., Lv, S., Gao, K., Liu, Y., et al. (2023) Circulating Tumor Cells (CTCs) and hTERT Gene Expression in CTCs for Radiotherapy Effect with Lung Cancer. BMC Cancer, 23, Article No. 475. [Google Scholar] [CrossRef] [PubMed]
[11] Zhu, Y., Chen, N., Chen, M., Cui, X., Yang, H., Zhu, X., et al. (2021) Circulating Tumor Cells: A Surrogate to Predict the Effect of Treatment and Overall Survival in Gastric Adenocarcinoma. The International Journal of Biological Markers, 36, 28-35. [Google Scholar] [CrossRef] [PubMed]
[12] 王刘星, 王黔. 循环肿瘤细胞在胃癌中应用的研究进展[J]. 安徽医药, 2023, 27(9): 1736-1740.
[13] 车凯军, 查国华, 龙剑. 循环肿瘤细胞在晚期结直肠癌化疗疗效评价的价值探讨[J]. 江西医药, 2021, 56(8): 1147-1149.
[14] Singh, T., Fatehi Hassanabad, M. and Fatehi Hassanabad, A. (2021) Non-Small Cell Lung Cancer: Emerging Molecular Targeted and Immunotherapeutic Agents. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1876, Article 188636. [Google Scholar] [CrossRef] [PubMed]
[15] Cueva Bañuelos, J.F., Rodríguez López, C., Cortegoso Mosquera, A., Palacios Ozores, P. and Curiel García, T. (2020) Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer. In: Piñeiro, R., Eds., Circulating Tumor Cells in Breast Cancer Metastatic Disease, Springer International Publishing, 147-164. [Google Scholar] [CrossRef] [PubMed]
[16] Zhao, L., Song, J., Sun, Y., Ju, Q., Mu, H., Dong, X., et al. (2023) Tumor‐Derived Proliferative CTCs and CTC Clusters Predict Aggressiveness and Early Recurrence in Hepatocellular Carcinoma Patients. Cancer Medicine, 12, 13912-13927. [Google Scholar] [CrossRef] [PubMed]
[17] Bidard, F., Jacot, W., Kiavue, N., Dureau, S., Kadi, A., Brain, E., et al. (2021) Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-Line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial. JAMA Oncology, 7, 34-41. [Google Scholar] [CrossRef] [PubMed]
[18] Raza, A., Khan, A.Q., Inchakalody, V.P., Mestiri, S., Yoosuf, Z.S.K.M., Bedhiafi, T., et al. (2022) Dynamic Liquid Biopsy Components as Predictive and Prognostic Biomarkers in Colorectal Cancer. Journal of Experimental & Clinical Cancer Research, 41, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
[19] Ye, Q., Ling, S., Zheng, S. and Xu, X. (2019) Liquid Biopsy in Hepatocellular Carcinoma: Circulating Tumor Cells and Circulating Tumor DNA. Molecular Cancer, 18, Article No. 114. [Google Scholar] [CrossRef] [PubMed]
[20] Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., et al. (2021) Circulating Tumor Cells: Biology and Clinical Significance. Signal Transduction and Targeted Therapy, 6, Article No. 404. [Google Scholar] [CrossRef] [PubMed]
[21] Tinganelli, W. and Durante, M. (2020) Tumor Hypoxia and Circulating Tumor Cells. International Journal of Molecular Sciences, 21, Article 9592. [Google Scholar] [CrossRef] [PubMed]
[22] Frithiof, H., Welinder, C., Larsson, A., Rydén, L. and Aaltonen, K. (2015) A Novel Method for Downstream Characterization of Breast Cancer Circulating Tumor Cells Following Cellsearch Isolation. Journal of Translational Medicine, 13, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
[23] Tarazona, N., Gimeno-Valiente, F., Gambardella, V., Zuñiga, S., Rentero-Garrido, P., Huerta, M., et al. (2019) Targeted Next-Generation Sequencing of Circulating-Tumor DNA for Tracking Minimal Residual Disease in Localized Colon Cancer. Annals of Oncology, 30, 1804-1812. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, J., Lian, J., Chen, Y., Zhao, X., Du, C., Xu, Y., et al. (2021) Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-Invasive Biomarkers of Therapeutic Response. Frontiers in Genetics, 12, Article 734595. [Google Scholar] [CrossRef] [PubMed]
[25] 伍远浩, 黄平, 李来春. 平均血小板体积和循环肿瘤细胞对结直肠癌术后复发转移的预测价值[J]. 中国现代普通外科进展, 2023, 26(11): 873-877.
[26] Zhou, H., Zhu, L., Song, J., Wang, G., Li, P., Li, W., et al. (2022) Liquid Biopsy at the Frontier of Detection, Prognosis and Progression Monitoring in Colorectal Cancer. Molecular Cancer, 21, Article No. 86. [Google Scholar] [CrossRef] [PubMed]
[27] Ignatiadis, M., Sledge, G.W. and Jeffrey, S.S. (2021) Liquid Biopsy Enters the Clinic—Implementation Issues and Future Challenges. Nature Reviews Clinical Oncology, 18, 297-312. [Google Scholar] [CrossRef] [PubMed]
[28] Cescon, D.W., Bratman, S.V., Chan, S.M. and Siu, L.L. (2020) Circulating Tumor DNA and Liquid Biopsy in Oncology. Nature Cancer, 1, 276-290. [Google Scholar] [CrossRef] [PubMed]
[29] Alix-Panabières, C. and Pantel, K. (2021) Liquid Biopsy: From Discovery to Clinical Application. Cancer Discovery, 11, 858-873. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, K., Wang, X., Pan, Q. and Zhao, B. (2023) Liquid Biopsy Techniques and Pancreatic Cancer: Diagnosis, Monitoring, and Evaluation. Molecular Cancer, 22, Article No. 167. [Google Scholar] [CrossRef] [PubMed]

为你推荐